• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Next Steps for Recovery and Rehab

    Scratching the Surface: A Roundtable on Coatings and Treatments

    Influencers on the Orthopedic Implant Manufacturing Market
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    ODT's Most-Read Stories This Week—Aug. 13

    Dental 3D Printing Market is Expanding 20% Annually

    Study Results Released for Abbott's Concussion Blood Test

    Bone Growth Stimulators Market to Top $3B by 2030

    Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    ODT's Most-Read Stories This Week—Aug. 13

    The ODT 2022 Top 10 Orthopedic Device Companies

    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Genetic Risk for Joint Replacement Failure
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Orthopedic Device Evolution is Driven by Precision Technology

    mdHACM Allografts Demonstrate Potential in Treating Knee Osteoarthritis

    Radically Improving Medicine & Surgery with Light Field Technology

    A Call to Action in Orthopedics: We Need to Personalize Every Single Hip and Knee Surgery

    Giving Knee Replacement Surgery a Much-Needed Update
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Modern Plastics

    Tiodize

    Braxton Manufacturing

    AV&R

    Life Science Outsourcing Inc.
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Online Exclusives

    Surgeon Creativity Shaping Orthobiologics Innovation

    Good relationships with surgeon customers can lead to collaborative development efforts.

    Surgeon Creativity Shaping Orthobiologics Innovation
    Related CONTENT
    • Steri-Tek
    • SeaSpine Begins Limited Rollout of WaveForm A (ALIF) 3D-Printed Interbody
    • Celularity, Arthrex Forge Supply and Distribution Deal
    • SeaSpine Launches WaveForm L 3D-Printed Interbodies
    • SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Michael Barbella, Managing Editor05.29.20
    Earlier this year, Bioventus marked the silver anniversary of a bone healing treatment system that repairs fractures via pulsed ultrasound waves. In touting the milestone, the company said its EXOGEN Ultrasound Bone Healing device has been used to treat more than 1 million patients globally, including English rugby star Olly Barkley, Norwegian World Cup and Olympic skier Magnus Moan, NFL tight end Greg Olsen, and professional hockey player Kyle Ostrow.
     
    Since its 1995 launch, EXOGEN has been prescribed by more than 10,000 physicians and sold in 15 countries. The device uses low-intensity pulsed ultrasound waves to induce micromechanical stress in fractures, amplifying the body’s natural bone repair mechanism. Studies have linked EXOGEN to an 86 percent heal rate for stubborn fractures and a 38 percent quicker healing time for fresh fractures. Bioventus claims its technology is supported by 16 Level 1 studies, but a 2016 McMaster University clinical trial found the device to be ineffective.
     
    Despite the study data disparity, EXOGEN has been a solid source of growth for Bioventus, accounting for roughly $100 million in annual worldwide sales. Part of its success can be attributed to the rising popularity of orthobiologics (a.k.a., regenerative cellular therapies), a category of biologically-based substances used to help orthopedic injuries heal more quickly. Orthobiologics are made from substances found naturally in the body, and they generally are used to improve the healing of fractures, injured muscles, tendons, and ligaments. The global orthobiologics market is forecast to grow 5.5 percent over the next seven years, driven by the world’s aging population, expanding waistlines, and increasing numbers of orthopedic conditions and musculoskeletal diseases. “Orthobiologics are revolutionizing orthopedic care,” Ignatios Papas, D.O., a non-surgical orthopedic physician in Tampa Bay, Fla., wrote in a blog last December. “Despite this, many patients don’t realize that these substances exist and can help them recover from orthopedic injuries, often without surgery.”
     
    ODT’s January/February feature, “Nature’s Way,” explores the various trends and challenges driving the global orthobiologics market. James J. Cassidy, Ph.D., president and chief operating officer of Artoss Inc., was among the experts interviewed for the story. His full input is provided in the following Q&A.
     
    Michael Barbella: Please discuss the current trends you see shaping the orthobiologics market. 
    James J. Cassidy: Stem cells seem to be declining in popularity as price pressures from hospitals as well as a lack of solid clinical data has called into question stem cells’ value proposition. Surgeons have begun moving back to using Infuse as alternative treatments have come up short. NanoBone Bone Graft is one of a handful of truly novel technologies that have entered the market in the last 10 years. As surgeons continue to look for new and better technologies, NanoBone continues to gain market share.
     
    Barbella: What factors are driving innovation in the orthobiologics market?
    Cassidy: Regulatory changes continue to affect innovation as well as challenges in gaining hospital approvals for new technology. As the main market for orthobiologics, spine surgery, continues to consolidate, hospital contracts with the largest spinal device companies create a barrier to entry for emergent orthobiologics.
     
    Barbella: What factors are impeding growth in the orthobiologics market?
    Cassidy: Lengthy and expensive regulatory review cycles and lack of venture capital spending in medical devices hinder growth.
     
    Barbella: How can these challenges be overcome?
    Cassidy: Changes to existing FDA regulations would enhance time to market for new orthobiologics most.
     
    Barbella: What new (orthobiologics) technologies are in the works?
    Cassidy: Artoss is committed to developing a number of surgical tool kits that facilitate implantation of NanoBone. Most orthobiologics companies are content in providing only an orthobiologic to their surgeon customers. Artoss has five products under development that will help surgeons address difficult cases in new and unique ways using NanoBone.
     
    Barbella: Where does innovation come from in the orthobiologics market? How does your company stay innovative amid all the competition?
    Cassidy
    : Innovation comes mostly from the surgeons that face challenges using existing technologies. Surgeon creativity is where the best innovation originates. When this creativity is coupled with good engineering, truly unique products are the result. The starting point in this development process is to have good relationships with surgeon customers that lead to collaborative development efforts. Artoss is fortunate to have developed a number of great relationships with these key surgeons.
     
    Barbella: How does the regulatory landscape for orthobiologics differ (if at all) from other sectors of the orthopedic market? (hips, knees,spine, etc.). How does this impact product innovation?
    Cassidy
    : In general, the FDA device panel is the same across the orthopedic market. Orthobiologics regulatory submissions can be a little more science-driven, but ultimately the FDA reviewers have done a good job in keeping up with the innovation allowing for a reasonable regulatory review cycle. Product innovation slows only when a new product requires prospective randomized human data for approval. This process can cost over $50 million and take up to 10 years to complete. Due to the rapid evolution of medical devices, most companies are reluctant to invest in this process due to the risk that a "new" product under review would be obsolete by the time regulatory approval has been achieved.
     
    Barbella: What is the dominant orthobiologics application - spinal fusion, trauma repair, reconstructive surgery? What factors are driving growth in this particular application?
    Cassidy: The dominant application for orthobiologics for the last 20 years has been spinal fusions. Spinal fusions use the greatest volume per case and the case volumes are very high. Growth in spinal surgeries continues at a slow and steady pace mostly impacted by increased total surgical volume. The increase in spinal surgeries is mostly dependent on changing demographics—an aging population. Other areas of orthopedics continue to evolve and are starting to require higher volumes of orthobiologics.
     
    Suggested For You
    Steri-Tek Steri-Tek
    SeaSpine Begins Limited Rollout of WaveForm A (ALIF) 3D-Printed Interbody SeaSpine Begins Limited Rollout of WaveForm A (ALIF) 3D-Printed Interbody
    Celularity, Arthrex Forge Supply and Distribution Deal Celularity, Arthrex Forge Supply and Distribution Deal
    SeaSpine Launches WaveForm L 3D-Printed Interbodies SeaSpine Launches WaveForm L 3D-Printed Interbodies
    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    GreenBone Ortho Closes 10 Million Euros Series B Funding Round GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    SeaSpine to Acquire 7D Surgical for $110M SeaSpine to Acquire 7D Surgical for $110M
    Surgalign Launches New Device for Bone Formation Surgalign Launches New Device for Bone Formation
    Locate Bio’s CognitOss for Chronic Osteomyelitis Earns Breakthrough Status Locate Bio’s CognitOss for Chronic Osteomyelitis Earns Breakthrough Status
    SeaSpine Launches Meridian ALIF System SeaSpine Launches Meridian ALIF System
    Orthobiologics Market to Reach $8.7 Billion By 2027 Orthobiologics Market to Reach $8.7 Billion By 2027

    Related Buyers Guide Companies

    • Steri-Tek

      Steri-Tek

      ...
      Jeff Sauter, Director Business Development 05.26.22

    • 3-D Printing/Additive Mfg. | Spine/Neurology
      SeaSpine Begins Limited Rollout of WaveForm A (ALIF) 3D-Printed Interbody

      SeaSpine Begins Limited Rollout of WaveForm A (ALIF) 3D-Printed Interbody

      Seamlessly integrates with the entire Meridian anterior interbody portfolio.
      GlobeNewswire 08.16.21

    • Biologics
      Celularity, Arthrex Forge Supply and Distribution Deal

      Celularity, Arthrex Forge Supply and Distribution Deal

      Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine.
      Globe Newswire 07.02.21


    • Spine/Neurology
      SeaSpine Launches WaveForm L 3D-Printed Interbodies

      SeaSpine Launches WaveForm L 3D-Printed Interbodies

      Designed for the LLIF (lateral lumbar interbody fusion) procedure.
      GlobeNewswire 06.09.21

    • 3-D Printing/Additive Mfg. | Spine/Neurology
      SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies

      SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies

      The TLIF Oblique System is the company's third entry into the 3D-printed interbody space.
      Sam Brusco, Associate Editor 04.20.21

    Loading, Please Wait..

    Trending
    • MdHACM Allografts Demonstrate Potential In Treating Knee Osteoarthritis
    • Bioventus Launches DUROLANE In The U.S.
    • Custom 3D-Printed Titanium Lower Jaw Used In First Successful Surgery
    • ARCH Medical Solutions Acquires Titan Medical Manufacturing
    • Future Stars Of The Spine Industry: The Companies To Watch, 2021
    Breaking News
    • ODT's Most-Read Stories This Week—Aug. 13
    • Dental 3D Printing Market is Expanding 20% Annually
    • Study Results Released for Abbott's Concussion Blood Test
    • Bone Growth Stimulators Market to Top $3B by 2030
    • Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Additive Manufacturing at the Point of Care
    • Six Orthopedic Firms En Route to Significant Market Disruption
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Aug. 13
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Consumers are Clamoring for Vintage Glam: Spate
    Kayali’s Lovefest Fragrance, Newell’s New Candle and HydraFacial’s Record Financial Results
    Self Care Trumps Home Care Post-Covid
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Aug. 13
    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login